Albert KGMM, Zimmet P, Shaw J(2005)International Diabetic Federation, (IDF), Epidemiology Task Force Consensus Group. The Metabolic Syndrome - a new worldwide definition. Lancet 366(9491):1059-1062.
Crossref

Allain CC, Poon LS, Clau CGS, Richmond W, Fu PD (1974). Enzymatic determination of total cholesterol. Clinical chemistry 20(4):470-475.
Crossref

Balkau B, Charles MA(1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes medication 16: 442-443.
Crossref

Buccolo G, David H (1973). Quatitative determination of serum triglycerides by the use of enzymes. Clinical Chemistry 19(4):4760 482.
Crossref

Chen W, Srinivasan SR, Elkasabany A, Berenson GS (1999). Cardiovascular risk factor clustering features of insulin resistance syndrome, (Syndrome X) in a biracial (blck-white) population of children, adolescents and young adults: The Bogahisa Heart Study. American Journal of Epidemiology 150(7):667-674.
Crossref

Dacie JV, Lewis SM (1975). Practical Haematology (1 - 20). 5th Edition ELBS and Churchill Livingstone pp. 609-609.

Downs JR, Clerafeld M, Weiss S, Whitney E, Shapiro DR, Beere' PA, Langendorf A, Stein EA, Kruyger W, Gotto AM.Jr (1988). Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Journal of American Medical Association 279(20):1615-1622.
Crossref

Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocrine Practice 9(3):237-252.
Crossref

Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, (2001). Executive Summary of the Third Report of the National Cholesterol Evaluation Programme/ Adult Treatment Panel 111 (NCEP/ATP111). Circulation 106(25):3143-3421
Crossref

Fontaine KR, Cheskin LJ, Barofsky I (1996). Health-related quality of life in obese persons seeking treatment. Journal of Family Practice 43(1):265-270.

Gray RS, Fabsitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ (1998). Risk factor clustering in the insulin resistance syndrome: The Strong Heart Study. American Journal of Epidemiology 148:869 -878.
Crossref

Grundy SM, Cleeman JI, Daurels SR, Donato KA, Eckel RH, Franklin B, Gordon DJ, Krauss RM, Savage PJ, Smith SR, Jr Spertus JA, Costa F (2005 b). Diagnosis and management of the metabolic syndrome; a statement for healthcare professionals: an American Heart Association/National Heart, Lung, and Blood Institute scientific Statement. Circulation 112(21):2735-2752.
Crossref

Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM (2004). Prevalence of overweight and obesity in US children, adolescent and adults, 19992002. Journal of American Medical Association 291(23):2847-2850.
Crossref

Huang Z, Willet WC, Manson JE, Rosner B, Stampfer MJ, Speizer FE, Colditz GA (1998). Body weight, weight change and the risk of hypertension in women. Annals of Internal Medicine 128(1):81-88.
Crossref

Krauss RM, Winston M, Fletcher RN, Grundy SM (1998). Obesity: impact of cardiovascular disease. Circulation 98(15):1472-1476.
Crossref

Meigs JB, D' Agostino RBS, Wilson PW, Gupples LA, Nathan DM, Singer DE (1977). Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes 46(10):1594- 1600.
Crossref

Musta A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH (1999). The disease burden associated with overweight and obesity. Journal of American Medical Association 282(16):1523-1529.
Crossref

Ogbu Innocent SI, Chukwukelu Ekene E (2015). Relative Significance of Waist Circumference, Body Mass Index and Waist-Hip Ratio as Predictors of the Metabolic Syndrome in an Apparently Healthy Nigerian Population. Journal of Disease and Global Health 4(1):17-21.

Ogbu Innocent SI (2009). Incidence of metabolic syndrome among hospital-based patients in the University of Nigeria Teaching Hospital and apparently healthy people in Enugu metropolis an PhD thesis submitted to the University of Calabar, Nigeria.

Pasquale Strazzullo , Antonio Barbato, Alfonso Siani, Francesco P Cappuccio, Marco Versiero, Pierluigi Schiattarella, Ornella Russo, Sonia Avallone, Elisabetta della Valle, Eduardo Farinaro. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Metabolism. 2008 Mar; 57(3):355-361.
Crossref

Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP (2001). Clustering of procoagulation, inflammation and fibrinolysis variables with metabolic factor in insulin resistance syndrome.American Journal of Epidemiology 152(10):897-907.
Crossref

Willet MC, Manson JE, Stampfer MJ, Colditz GA, Rosner B Speizer CH, Hennekens CH (1995). Weight, weight change and coronary heart disease in women: risk within the 'normal' weight range. Journal of American Medical Association 273(6):461-465.
Crossref

World Health Organization (1999). Definition, diagnosis and classification of diabtes mellitus. Geneva, WHO department of Non-Communicable disease Surveillance.

World Health Organization (2000). Obesity; preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894:1-263.